Cargando…

Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study

OBJECTIVE: To evaluate which risk factors for RhD immunisation remain, despite adequate routine antenatal and postnatal RhIg prophylaxis (1000 IU RhIg) and additional administration of RhIg. The second objective was assessment of the current prevalence of RhD immunisations. DESIGN: Prospective cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Slootweg, Y. M., Zwiers, C., Koelewijn, J. M., van der Schoot, E., Oepkes, D., van Kamp, I. L., de Haas, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543810/
https://www.ncbi.nlm.nih.gov/pubmed/35133072
http://dx.doi.org/10.1111/1471-0528.17118
_version_ 1784804460942327808
author Slootweg, Y. M.
Zwiers, C.
Koelewijn, J. M.
van der Schoot, E.
Oepkes, D.
van Kamp, I. L.
de Haas, M.
author_facet Slootweg, Y. M.
Zwiers, C.
Koelewijn, J. M.
van der Schoot, E.
Oepkes, D.
van Kamp, I. L.
de Haas, M.
author_sort Slootweg, Y. M.
collection PubMed
description OBJECTIVE: To evaluate which risk factors for RhD immunisation remain, despite adequate routine antenatal and postnatal RhIg prophylaxis (1000 IU RhIg) and additional administration of RhIg. The second objective was assessment of the current prevalence of RhD immunisations. DESIGN: Prospective cohort study. SETTING: The Netherlands. POPULATION: Two‐year nationwide cohort of alloimmunised RhD‐negative women. METHODS: RhD‐negative women in their first RhD immunised pregnancy were included for risk factor analysis. We compared risk factors for RhD immunisation, occurring either in the previous non‐immunised pregnancy or in the index pregnancy, with national population data derived from the Dutch perinatal registration (Perined). RESULTS: In the 2‐year cohort, data from 193 women were eligible for analysis. Significant risk factors in women previously experiencing a pregnancy of an RhD‐positive child (n = 113) were: caesarean section (CS) (OR 1.7, 95% CI 1.1–2.6), perinatal death (OR 3.5, 95% CI 1.1–10.9), gestational age >42 weeks (OR 6.1, 95% CI 2.2–16.6), postnatal bleeding (>1000 ml) (OR 2.0, 95% CI 1.1–3.6), manual removal of the placenta (MRP) (OR 4.3, 95% CI 2.0–9.3); these factors often occurred in combination. The miscarriage rate was significantly higher than in the Dutch population (35% versus 12.‐5%, P < 0.001). CONCLUSION: Complicated deliveries, including cases of major bleeding and surgical interventions (CS, MRP), must be recognised as a risk factor, requiring estimation of fetomaternal haemorrhage volume and adjustment of RhIg dosing. The higher miscarriage rate suggests that existing RhIg protocols need adjustment or better compliance. TWEETABLE ABSTRACT: Complicated delivery (caesarean section, manual removal placenta, major bleeding) is the most valid risk factor for RhD immunization despite antenatal and postnatal RhIg.
format Online
Article
Text
id pubmed-9543810
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95438102022-10-14 Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study Slootweg, Y. M. Zwiers, C. Koelewijn, J. M. van der Schoot, E. Oepkes, D. van Kamp, I. L. de Haas, M. BJOG RESEARCH ARTICLES OBJECTIVE: To evaluate which risk factors for RhD immunisation remain, despite adequate routine antenatal and postnatal RhIg prophylaxis (1000 IU RhIg) and additional administration of RhIg. The second objective was assessment of the current prevalence of RhD immunisations. DESIGN: Prospective cohort study. SETTING: The Netherlands. POPULATION: Two‐year nationwide cohort of alloimmunised RhD‐negative women. METHODS: RhD‐negative women in their first RhD immunised pregnancy were included for risk factor analysis. We compared risk factors for RhD immunisation, occurring either in the previous non‐immunised pregnancy or in the index pregnancy, with national population data derived from the Dutch perinatal registration (Perined). RESULTS: In the 2‐year cohort, data from 193 women were eligible for analysis. Significant risk factors in women previously experiencing a pregnancy of an RhD‐positive child (n = 113) were: caesarean section (CS) (OR 1.7, 95% CI 1.1–2.6), perinatal death (OR 3.5, 95% CI 1.1–10.9), gestational age >42 weeks (OR 6.1, 95% CI 2.2–16.6), postnatal bleeding (>1000 ml) (OR 2.0, 95% CI 1.1–3.6), manual removal of the placenta (MRP) (OR 4.3, 95% CI 2.0–9.3); these factors often occurred in combination. The miscarriage rate was significantly higher than in the Dutch population (35% versus 12.‐5%, P < 0.001). CONCLUSION: Complicated deliveries, including cases of major bleeding and surgical interventions (CS, MRP), must be recognised as a risk factor, requiring estimation of fetomaternal haemorrhage volume and adjustment of RhIg dosing. The higher miscarriage rate suggests that existing RhIg protocols need adjustment or better compliance. TWEETABLE ABSTRACT: Complicated delivery (caesarean section, manual removal placenta, major bleeding) is the most valid risk factor for RhD immunization despite antenatal and postnatal RhIg. John Wiley and Sons Inc. 2022-03-18 2022-09 /pmc/articles/PMC9543810/ /pubmed/35133072 http://dx.doi.org/10.1111/1471-0528.17118 Text en © 2022 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle RESEARCH ARTICLES
Slootweg, Y. M.
Zwiers, C.
Koelewijn, J. M.
van der Schoot, E.
Oepkes, D.
van Kamp, I. L.
de Haas, M.
Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
title Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
title_full Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
title_fullStr Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
title_full_unstemmed Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
title_short Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
title_sort risk factors for rhd immunisation in a high coverage prevention programme of antenatal and postnatal rhig: a nationwide cohort study
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543810/
https://www.ncbi.nlm.nih.gov/pubmed/35133072
http://dx.doi.org/10.1111/1471-0528.17118
work_keys_str_mv AT slootwegym riskfactorsforrhdimmunisationinahighcoveragepreventionprogrammeofantenatalandpostnatalrhiganationwidecohortstudy
AT zwiersc riskfactorsforrhdimmunisationinahighcoveragepreventionprogrammeofantenatalandpostnatalrhiganationwidecohortstudy
AT koelewijnjm riskfactorsforrhdimmunisationinahighcoveragepreventionprogrammeofantenatalandpostnatalrhiganationwidecohortstudy
AT vanderschoote riskfactorsforrhdimmunisationinahighcoveragepreventionprogrammeofantenatalandpostnatalrhiganationwidecohortstudy
AT oepkesd riskfactorsforrhdimmunisationinahighcoveragepreventionprogrammeofantenatalandpostnatalrhiganationwidecohortstudy
AT vankampil riskfactorsforrhdimmunisationinahighcoveragepreventionprogrammeofantenatalandpostnatalrhiganationwidecohortstudy
AT dehaasm riskfactorsforrhdimmunisationinahighcoveragepreventionprogrammeofantenatalandpostnatalrhiganationwidecohortstudy